| Mohammad Taha, MD | |
|
Ku Medical Center Div Og General &, 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160-0001 | |
| (913) 588-6005 | |
| (913) 588-3877 |
| Full Name | Mohammad Taha |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | Ku Medical Center Div Og General &, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164452058 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 04-32653 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.
Patients with rheumatoid arthritis (RA), the most common chronic inflammatory arthritis, are twice as likely as other individuals to experience depression.
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.
Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.
› Verified 8 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.
Patients with rheumatoid arthritis (RA), the most common chronic inflammatory arthritis, are twice as likely as other individuals to experience depression.
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.
Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Taha, MD Kansas University Physicians Inc, 3901 Rainbow Blvd ,4070 Delp, Ms 4017, Kansas City, KS 66160-0001 Ph: (913) 588-2500 | Mohammad Taha, MD Ku Medical Center Div Og General &, 3901 Rainbow Blvd, Ms 1020, Kansas City, KS 66160-0001 Ph: (913) 588-6005 |
News Archive
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.
Patients with rheumatoid arthritis (RA), the most common chronic inflammatory arthritis, are twice as likely as other individuals to experience depression.
The head of Indonesia's national committee on avian influenza has announced that scientists there have developed a bird flu vaccine for humans.
Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.
Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.
› Verified 8 days ago
Aiman Zafar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6000 | |
Michael Aaron Albrecht, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Olathe Blvd, Kansas City, KS 66160 Phone: 913-945-8184 Fax: 913-588-6055 | |
Muhammad Atif Khan, MD Hospitalist Medicare: Medicare Enrolled Practice Location: University Of Kansas Health System. 4000 Cambridge St, 6040 Delp Ms 1020, Kansas City, KS 66160 Phone: 913-588-5165 | |
Bidhan Kunwar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Michael Burton, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5080 Fax: 913-588-6055 | |
Margaret Nulton, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 |